COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,758 Articles (22,943 medRxiv, 8,815 bioRxiv)

Most recent first Previous |  Page 1030: Articles 10291-10300  | Next

Host Chitinase 3-like-1 is a Universal Therapeutic Target for the Delta, Omicron and Other SARS-CoV-2 Viral Variants in COVID 19
Kamle, S., Ma, B., Lee, C. M., Schor, G., Lee, C. G., Elias, J. A.
10.1101/2022.01.21.477274 — Posted: 2022-01-24
Severe acute respiratory disease in American mink (Neovison vison) experimentally infected with SARS-CoV-2
Adney, D. R., Lovaglio, J., Schulz, J. E., Yinda, C. K., Avanzato, V. A., Haddock, E., Port, J. R., Holbrook, M., Hanley, P. W., Saturday, G., Scott, D., Spengler, J. R., Tansey, C., Cossaboom, C., Wendling, N., Martens, C., Easley, J., Yap, S. W., Seifert, S. N., Munster, V. J.
10.1101/2022.01.20.477164 — Posted: 2022-01-24
Risk factors for developing symptomatic COVID-19 in older residents of nursing homes: A hypothesis-generating observational study
Minobes-Molina, E., Escriba-Salvans, A., Rierola-Fochs, S., Farres-Godayol, P., Molas-Tuneu, M., Bezerra de Souza, D. L., Skelton, D. A., Goutan-Roura, E., Alonso-Masmitja, D., Jerez-Roig, J.
10.1101/2022.01.18.22269433 — Posted: 2022-01-24
Vaccine hesitancy and access to psoriasis care in the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey.
Bechman, K., Cook, E., Dand, N., Yiu, Z., Tsakok, T., Meynell, F., Coker, B., Vincent, A., Bachelez, H., Barbosa, I., Brown, M., Capon, F., Contreras, C., De La Cruz, C., Di Meglio, P., Gisondi, P., Jullien, D., Kelly, J., Lambert, J., Lancelot, C., Langan, S., Mason, K., McAteer, H., Moorhead, L., Naldi, L., Norton, S., Puig, L., Spuls, P., Torres, T., Urmston, D., Vesty, A., Warren, R., Waweru, H., Weinman, J., Griffiths, C., Barker, J., Smith, C., Galloway, J., Mahil, S.
10.1101/2022.01.20.22269546 — Posted: 2022-01-23
SARS-CoV-2 Viral Genes Compromise Survival and Functions of Human Pluripotent Stem Cell-derived Cardiomyocytes via Reducing Cellular ATP Level
Liu, J., Zhang, Y., Wu, S., Han, L., Wang, C., Liu, S., Simpson, E., Liu, Y., Wang, Y., Shou, W., Liu, Y., Rubart-von der Lohe, M., Wan, J., Wan, J., Yang, L.
10.1101/2022.01.20.477147 — Posted: 2022-01-23
Impact of accelerating booster vaccination amidst Omicron surge in the United States
Sah, P., Nogueira Vilches, T., Moghadas, S. M., Fitzpatrick, M. C., Schneider, E. C., Galvani, A. P.
10.1101/2022.01.22.22269655 — Posted: 2022-01-23
A Cross-Country Analysis of the Effectiveness of COVID-19 Vaccines in Reducing Mortality Rates within the EU
Bliznashki, S.
10.1101/2022.01.23.22269604 — Posted: 2022-01-23
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 S antibodies
Vargas, L., Valdivieso, N., Tempio, F., Simon, V., Sauma, D., Valenzuela, L., Beltran, C., Castillo-Delgado, L., Contreras-Benavides, X., Acevedo, M. L., Valiente-Echeverria, F., Soto-Rifo, R., Gonzalez, R. I., Lopez, M., Osorio, F., Bono, M. R.
10.1101/2022.01.14.22269289 — Posted: 2022-01-23
COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase
Mühle, C., Kremer, A., Vetter, M., Schmid, J., Achenbach, S., Schumacher, F., Lenz, B., Cougoule, C., Hoertel, N., Carpinteiro, A., Gulbins, E., Kleuser, B., Kornhuber, J.
10.1101/2022.01.19.22269391 — Posted: 2022-01-23 Discussion: Offsite
Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021
Backer, J. A., Eggink, D., Andeweg, S. P., Veldhuijzen, I. K., van Maarseveen, N., Vermaas, K., Vlaemynck, B., Schepers, R., van den Hof, S., Reusken, C., Wallinga, J.
10.1101/2022.01.18.22269217 — Posted: 2022-01-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).